NATIONAL HEALTHCARE CORP (NHC): what the price assumes

In the published model solve dated 2026-Q2, anchored at $222.70, NATIONAL HEALTHCARE CORP (NHC) is priced for +12.0% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-08-31 · Source: https://boothcheck.com/report/NHC

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.2% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.7%); the inversion above states its own rate.

Per-Model Detail (n=15)

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• National HealthCare runs a debt-free balance sheet that is rare in senior care: it carried zero current and long-term debt at the end of the first quarter and held about $258 million in cash and marketable securities, so it owns its operations outright rather than renting them from lenders.
• The biggest specific risk is payor mix: government programs are the core of the revenue, with Medicare alone at 33% of net patient revenue, so a change in Medicare or Medicaid reimbursement rates lands directly on the operating margin, which is already thin at about 8.5%.
• Watch skilled nursing occupancy, which averaged 90.0% in the first quarter, against the demographic tailwind of an aging population that should keep demand for the company's 80 skilled nursing facilities rising.

Bull Case

The one number that defines National HealthCare is its debt. There is none. At the end of the first quarter the company reduced both current and long-term debt to zero, down from $40 million at year end, and held roughly $258 million in cash and marketable securities. In an industry where most operators run on leverage and lease their buildings, a skilled nursing company that owns its operations free of debt is a structural outlier. It means the entire operating cash flow belongs to shareholders rather than being routed to lenders first, and it means a bad reimbursement year is survivable without a refinancing scare. That financial position is the foundation everything else rests on.

The operating business behind it is steady and demographically favored. National HealthCare operates 80 skilled nursing facilities with more than 10,000 beds, plus assisted living, independent living, homecare, hospice, and behavioral health, and skilled nursing occupancy averaged 90.0% in the first quarter. Demand for skilled nursing is tied to an aging population, a slow-moving tailwind that does not depend on the economy. The company's facilities are embedded in the public reimbursement system; its filing notes that all of its skilled nursing facilities are "certified to participate in Medicare," which is the credential required to serve the largest payor base in senior care.

The recent results show operating leverage working in the company's favor. First-quarter revenue rose 2.2% to $381.8 million while costs grew more slowly, lifting GAAP net income to $35.9 million and diluted earnings per share to $2.27, up from $2.07 a year earlier. Management raised the quarterly dividend to 64 cents from 61 cents, funded comfortably out of operating cash flow given the absence of interest payments. For a buyer at today's price, the bull case is a conservatively financed operator in a demand-growing niche, converting modest revenue growth into faster earnings growth and returning the surplus to holders, with a balance sheet that removes the refinancing risk that haunts its leveraged peers.

Bear Case

The uncomfortable truth for a holder is that National HealthCare is a low-margin business whose pricing is set by the government, not by the company. It earns an operating margin of about 8.5%, which is thin, and a large share of its revenue comes from programs whose rates are decided in Washington and state capitals. The filing lays out the payor mix directly, with Medicare at "33%" of net patient revenue and a substantial further share from Medicaid, the state-run program for the indigent. When a payor that large sets your prices, a single unfavorable reimbursement update flows straight to the bottom line, and at an 8.5% margin there is little buffer to absorb it. The debt-free balance sheet protects against insolvency; it does not protect against a rate cut.

The valuation read is where the bear sharpens. The asset-based and earnings-power methods both place the price well above where they land, with the price sitting near twice the earnings-power estimate. Reading the price backward, the market is paying about 23 times operating income, which implies roughly 13% annual operating-profit growth for five years. That is achievable for the company in the near term, but only about half of comparable growers have sustained that pace for five full years, and for a business whose top line grew 2.2% last quarter, 13% operating-profit growth has to come from margin expansion rather than volume. Margin expansion in a labor-intensive, government-priced business is the hardest kind to sustain, because the cost side does not stay quiet.

Labor and revenue collection are the operational pressure points. The cost to retain and replace qualified staff is a structural feature of skilled nursing, and the filing flags that service revenue realization can be uncertain, that the company may make "expenditures related to the provision of services for which we are not paid." Wages are the largest cost in the business, and they tend to rise faster than reimbursement in tight labor markets, which compresses the very margin the price assumes will expand. The bear case is not that National HealthCare is fragile; the debt-free balance sheet makes it durable. The bear case is that the price assumes a margin trajectory that a government-priced, labor-heavy operator rarely delivers for five straight years.

Valuation

What the price assumes is modest growth that has to come from the right place. At today's level the market pays about 23 times operating income, which implies roughly 13% annual operating-profit growth sustained for five years. The framework reads that as within range of what is plausible, and the near-term pace is consistent with what the company has delivered. The subtlety is the source of that growth: with revenue growing only about 2% a year, the implied operating-profit growth must come mostly from margin expansion, so the price is really a bet on costs staying contained relative to reimbursement.

The methods disagree in a way that fits a steady, asset-light-in-spirit operator. The peer-multiple comparisons and the forward-growth methods support the price, reading it as fair against its healthcare-services cohort and against a reasonable growth path. The asset-based and earnings-power methods read it as expensive, with the price near twice the earnings-power estimate. The gap reflects what those methods measure: the asset and earnings-power lenses anchor on the current, thin margin and the modest book value of the operations, while the relative and growth methods credit the demand tailwind and the operating leverage. For a business with a demographic wind at its back, the forward-looking methods deserve weight, but the earnings-power read is the honest warning that the price already embeds margin improvement.

Solvency is the part that needs no qualification, and it is the company's defining strength. National HealthCare carries no debt, holds about $258 million in cash and marketable securities, and generated trailing operating income near $130 million, so interest coverage is effectively limitless and the dividend is funded many times over. A buyer is not underwriting any balance-sheet risk; the entire question is operating. The decisive variable is the margin: if the company keeps growing earnings faster than revenue by holding labor and operating costs below reimbursement, the price is fair; if government rates tighten or wages accelerate, the earnings-power methods that call it expensive will have been right.

Catalysts

The clearest recent catalyst was the first-quarter result and the dividend increase that followed it. National HealthCare reported revenue of $381.8 million, up 2.2% year over year, GAAP net income of $35.9 million, and diluted earnings per share of $2.27, with companywide operating margins improving as salaries, wages, and other operating costs grew more slowly than revenue. The board raised the quarterly dividend to 64 cents from 61 cents, a signal of confidence backed by the debt-free balance sheet.

Reimbursement policy is the catalyst that matters most over the next year, because it sets the company's prices. With Medicare at 33% of net patient revenue and Medicaid a further large share, the annual updates to those programs are the single largest external driver of the margin. Any change in federal or state reimbursement rates feeds directly into a business operating on an 8.5% margin, so the policy calendar is the one to watch.

The operating threads are occupancy and footprint. Skilled nursing occupancy averaged 90.0% in the quarter, and the company operates 80 skilled nursing facilities with more than 10,000 beds alongside its assisted living, homecare, and hospice operations. Whether occupancy holds or rises as the aging population grows, and whether the company keeps labor costs below reimbursement, are the operational catalysts that determine the earnings path.

Peer Cohorts (Per Segment, With Filing Citations)

Inpatient Services (reported)

• ENSG (ENSIGN GROUP, INC)
• FY2025 10-K: , reviews segment income for each operating segment to evaluate performance and allocate capital resources. For more information about our operating segments, as well as financial information, see Part II., Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and Note 7,…
• FY2025 10-K: $ 272,762 (1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in…
• SEM (SELECT MEDICAL HOLDINGS CORP)
• FY2025 10-K: …that refer patients to our rehabilitation hospitals. We provide our facilities within our rehabilitation hospital segment with centralized accounting, treasury, payroll, legal, operational support, human resources, compliance, management information systems, health information, credentialing, physician contracting…
• FY2025 10-K: …conditions requiring rehabilitative healthcare services in an inpatient setting. These conditions require targeted therapy and rehabilitation treatment, including comprehensive rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric…
• ARDT (Ardent Health, Inc.)
• FY2025 10-K: …gross inpatient and outpatient revenue to gross inpatient revenue. Gross inpatient and outpatient revenue reflect gross inpatient and outpatient charges prior to estimated contractual adjustments, uninsured discounts, implicit price concessions, and other discounts. The calculation of adjusted admissions is…
• FY2025 10-K: …our total revenue and our operating margins. Results of Operations Revenue and Volume Trends Our revenue depends upon inpatient occupancy levels, ancillary services and therapy programs ordered by physicians and provided to patients, the volume of outpatient procedures and the charges and negotiated payment rates for…
• ACHC (Acadia Healthcare Company, Inc.)
• FY2025 10-K: …services, the Company recognizes revenue equally over the patient stay on a daily basis. For outpatient services, the Company recognizes revenue equally over the number of treatments provided in a single episode of care. Typically, patients and third-party payors are billed within several days of the service being…
• FY2025 10-K: …are based on contractual agreements, discount policies and historical experience. Implicit price concessions are based on historical collection experience. We derive a significant portion of our revenue from Medicare, Medicaid and other payors that receive discounts from established billing rates. The Medicare and…
• BKD (BROOKDALE SENIOR LIVING INC.)
• FY2025 10-K: …their changing needs. Assisted Living and Memory Care. The Company's Assisted Living and Memory Care segment includes owned or leased communities that offer housing and 24-hour assistance with activities of daily living for the Company's residents. The Company's assisted living and memory care communities include…
• FY2025 10-K: …areas of compensation, leadership, career growth, and meaningful work. • Earn resident and family trust and satisfaction by providing valued, high-quality care and personalized service. We believe that fostering the continued trust of our residents and their families will allow us to build relationships that create…
• PACS (PACS Group, Inc.)
• FY2025 10-K: …and other payors such as commercial insurance companies, health maintenance organizations, and preferred provider organizations. We expect patient and resident service revenue to continue to represent the vast majority of our total revenue and that such revenue will continue to increase to the extent we successfully…
• FY2025 10-K: …care, assisted living, and independent living options in some of our communities. As of December 31, 2025, our portfolio consisted of 321 post-acute care, assisted living, and independent living facilities across 17 states serving over 31,700 patients daily. We believe our significant historical growth has been…

Homecare and Hospice (reported)

• ADUS (Addus HomeCare Corp)
• FY2025 10-K: …oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services. Many consumers need such services on a long-term basis to address chronic or acute conditions. Our personal care segment also includes staffing services, with clients including assisted…
• FY2025 10-K: …reconciliation: Items not allocated at segment level: Other general and administrative expenses 117,861 Depreciation and amortization 13,530 Interest income ( 4,394 ) Interest expense 7,732 Income before income taxes $ 99,353 ( 1 ) Other segment items include other costs for direct service personnel, office expense,…
• CHE (CHEMED CORPORATION)
• FY2025 10-K: …to settlements of audits and reviews, as well as certain hospice-specific revenue capitations. Amounts are generally billed monthly or subsequent to patient discharge. Subsequent changes in the transaction price initially recognized are not significant. Hospice services are provided on a daily basis and the type of…
• FY2025 10-K: …to hospices will not decrease. Reductions in amounts paid by government programs for services or changes in methods or regulations governing payments could cause VITAS' net patient service revenue and profits to materially decline. 15% to 20% of VITAS' days of care are provided to patients who reside in nursing…
• AVAH (Aveanna Healthcare Holdings Inc.)
• FY2025 10-K: …services and durable medical equipment, some of which may have greater financial and other resources and may be more established in their respective communities. Competing companies may offer newer or different services from those offered by us and may thereby attract customers who are presently receiving our home…
• FY2025 10-K: …home health and hospice services or similar services. If states with such existing laws remove such barriers, we could face increased competition in these states. We may encounter increased competition in the future that could negatively impact patient referrals to us, limit our ability to maintain or increase our…
• ENSG (ENSIGN GROUP, INC)
• FY2025 10-K: …HHS issued guidance to hospitals and long-term care facilities, emphasizing their obligation under CMS regulations to ensure non-discriminatory visitation policies, especially during public health emergencies. This guidance, part of the U.S. National Strategy to Counter Antisemitism, clarifies that these facilities…
• FY2025 10-K: …costs. 19 Table of Contents Home Health and Hospice Payment Rules Affecting SNFs - CMS's final payment rules for other modalities of care delivery also affect the operations of SNFs. Under the CY 2025 Home Health PPS, long-term care facilities, including SNFs, have been required to submit at least weekly reports to…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.